VMware Q1 12 Earnings Conference Call At 5:00 PM ET

Hell On Earth: The 10 Worst Nations For Health Care

Canadians Say Legal Marijuana Not A Temptation

Procter & Gamble Q3 Core EPS Up 4%; Organic Sales Up 1%

P&G To Buy Merck KgaA's Consumer Health Business For EUR 3.4 Bln

Alcoa Profit Tops Street, Shares Up 5%

Famous Ski Towns Sue Oil Giants For Climate Change

FCC Commissioner Mignon Clyburn Announces Resignation

"Racist" Starbucks To Close All Locations On May 29

Porsche Fast-tracks Charging Network Across America

Gorgeous New Website For Walmart

Goldman Sachs Q1 Results Beat View; Hikes Dividend

Netflix Stock Up 7% On Strong Subscriber Additions

GWPH Faces FDA Panel Tomorrow, NVCR Reports STELLAR Data, 1st XLH Drug Cleared

ALNY On Watch, NLNK Exhibits Caution, Keep An Eye On GKOS

Bunzl Q1 Group Revenue Rises; CEO Of Bunzl North America To Retire - Quick Facts

CHEK On Watch, ARQL Inks A Deal, RTTR To Move RP-G28 Into Phase III

APVO Walks The Talk, Eleven Bio Gains Over 13%, PADDOCK Data Boosts APLS

ALKS Pulls Off Sweet Surprise, APRI Thrashed, BMY Gets FDA Nod

GEA Group CFO Helmut Schmale To Take Early Retirement - Quick Facts

Starbucks Has Black Men Arrested For Nothing

In The Spotlight: SIGA Technologies

Volkswagen Trucks Unit Reportedly Considers Full Takeover Of Navistar

Vivendi Unit Acquires Paylogic - Quick Facts

CLDX Disappoints Investors, ASNS Awaits Data In 2H18, BPMC Fails To Make A Mark

Merck : KEYTRUDA-pemetrexed-platinum Chemotherapy Combination Improved OS

Volkswagen Trucks Unit Reportedly Considers Full Takeover Of Navistar

Pebblebrook Hotel Revises Non-binding Proposal For LaSalle Hotel Properties

Vodafone Non-Executive Director Mathias Döpfne To Stand Down

Aetna Announces Business Segment Realignment

Recall: Conagra's Salisbury Steaks With Bone Shards

Gorgeous New Website For Walmart

Big Lots President And CEO David Campisi Retires

Merck Begins Two Phase 3 Studies Of Pneumococcal Disease Vaccine PCV-15 (V114)

InterContinental FY Revenue Surges On Restatement

ALKS Pulls Off Sweet Surprise, APRI Thrashed, BMY Gets FDA Nod

CLDX Disappoints Investors, ASNS Awaits Data In 2H18, BPMC Fails To Make A Mark